These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 21953853

  • 1. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.
    Siragusa S, Malato A, Saccullo G, Iorio A, Di Ianni M, Caracciolo C, Coco LL, Raso S, Santoro M, Guarneri FP, Tuttolomondo A, Pinto A, Pepe I, Casuccio A, Abbadessa V, Licata G, Battista Rini G, Mariani G, Di Fede G.
    Am J Hematol; 2011 Nov; 86(11):914-7. PubMed ID: 21953853
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation.
    Prandoni P, Lensing AW, Prins MH, Pesavento R, Piccioli A, Sartori MT, Tormene D, Milan M, Vedovetto V, Noventa F, Villalta S, Harenberg J.
    Semin Thromb Hemost; 2015 Mar; 41(2):133-40. PubMed ID: 25682083
    [Abstract] [Full Text] [Related]

  • 5. Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.
    Kooistra HA, Gebel M, Sahin K, Lensing AW, Meijer K.
    Thromb Haemost; 2015 Nov 25; 114(6):1136-43. PubMed ID: 26224199
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral rivaroxaban for symptomatic venous thromboembolism.
    EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S.
    N Engl J Med; 2010 Dec 23; 363(26):2499-510. PubMed ID: 21128814
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
    Cosmi B, Legnani C, Iorio A, Pengo V, Ghirarduzzi A, Testa S, Poli D, Tripodi A, Palareti G, PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics).
    Eur J Vasc Endovasc Surg; 2010 Mar 23; 39(3):356-65. PubMed ID: 20034816
    [Abstract] [Full Text] [Related]

  • 13. Residual vein thrombosis and D-dimer for optimizing duration of anticoagulation in idiopathic deep vein thrombosis.
    Malato A, Saccullo G, Iorio A, Ageno W, Siragusa S.
    Curr Pharm Des; 2010 Mar 23; 16(31):3483-6. PubMed ID: 20858182
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.
    Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G.
    Thromb Haemost; 2011 May 23; 105(5):837-45. PubMed ID: 21359409
    [Abstract] [Full Text] [Related]

  • 17. Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms.
    Bryk AH, Wypasek E, Plens K, Awsiuk M, Undas A.
    Vascul Pharmacol; 2018 Jul 23; 106():22-27. PubMed ID: 29432897
    [Abstract] [Full Text] [Related]

  • 18. Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.
    Couturaud F, Pernod G, Presles E, Duhamel E, Jego P, Provost K, Pan-Petesch B, Sollier CBD, Tromeur C, Hoffmann C, Bressollette L, Lorillon P, Girard P, Le Moigne E, Le Hir A, Guégan M, Laporte S, Mismetti P, Lacut K, Bosson JL, Bertoletti L, Sanchez O, Meyer G, Leroyer C, Mottier D, “PADIS-DVT” investigators.
    Haematologica; 2019 Jul 23; 104(7):1493-1501. PubMed ID: 30606789
    [Abstract] [Full Text] [Related]

  • 19. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F, Sanchez O, Pernod G, Mismetti P, Jego P, Duhamel E, Provost K, dit Sollier CB, Presles E, Castellant P, Parent F, Salaun PY, Bressollette L, Nonent M, Lorillon P, Girard P, Lacut K, Guégan M, Bosson JL, Laporte S, Leroyer C, Décousus H, Meyer G, Mottier D, PADIS-PE Investigators.
    JAMA; 2015 Jul 07; 314(1):31-40. PubMed ID: 26151264
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.